Category: Association News

Sun Pharma Presents ODOMZO and LEVULAN KERASTICK + BLU-U Data, Offering Clinical Insights for Treating People with or at Risk of Skin Cancer

A wholly owned subsidiary of Sun Pharmaceutical Industries Ltd presented data analyses for two of its specialty medicines – ODOMZO (sonidegib) and LEVULAN KERASTICK (aminolevulinic acid HCl) + BLU-U – from its dermatology portfolio, providing insights to healthcare providers treating patients who have or are at risk for different types of skin cancer, according to a media release.

Read More

Sun Pharma Announces Long-term Insights into the Clinical Use of ILUMYA (tildrakizumab-asmn) in a Cross Section of People Living with Moderate-to-Severe Plaque Psoriasis

Sun Pharmaceutical Industries Ltd announces in a media release that one of its wholly owned subsidiaries presented further evidence of the long-term use and cost-effectiveness of ILUMYA (tildrakizumab-asmn) in moderate-to-severe plaque psoriasis at the American Academy of Dermatology (AAD) Virtual Meeting Experience 2020.

Read More

Johnson & Johnson Consumer Health Presents Findings from Ten-Year Infant and Mother Skin Microbiome Study at American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2020

Johnson & Johnson Consumer Health presented findings from a longitudinal study of infant and mother skin microbiome research at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2020, being held from June 12 – 14, 2020, according to a news release.

Read More
Loading